A phase 1 trial of Ultragenyx’ treatment for hereditary inclusion-body myopathy caused by GNE mutations is taking place in New York and California
New content is being added every day. Please check back again.
Muscular Dystrophy Association — USA National Office222 S. Riverside Plaza, Suite 1500Chicago, IL 60606(800) 572-1717
©2015, Muscular Dystrophy Association Inc. All rights reserved.